Oncorus IncNASDAQ:ONCRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4300
- TODAY'S CHANGE (%)0.0070 (1.6548%)
- Bid / Lots0.4224/ 4
- Ask / Lots0.4300/ 50
- Open / Previous Close0.4226 / 0.4230
- Day Range
- 52 Week Range
- Volume59,674
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ONCR |
|---|---|---|
| 09:32 ET | 200 | 0.4226 |
| 09:33 ET | 100 | 0.4398 |
| 09:35 ET | 111 | 0.439699 |
| 09:48 ET | 2967 | 0.4223 |
| 09:50 ET | 3100 | 0.4299 |
| 09:51 ET | 3000 | 0.429899 |
| 09:53 ET | 2000 | 0.4225 |
| 10:04 ET | 200 | 0.4299 |
| 10:06 ET | 400 | 0.4262 |
| 10:08 ET | 600 | 0.4236 |
| 10:09 ET | 7392 | 0.4222 |
| 10:11 ET | 313 | 0.4222 |
| 10:18 ET | 100 | 0.4222 |
| 10:20 ET | 100 | 0.4222 |
| 10:24 ET | 1301 | 0.4223 |
| 10:26 ET | 3673 | 0.4222 |
| 10:27 ET | 200 | 0.4222 |
| 10:29 ET | 100 | 0.4223 |
| 10:38 ET | 2000 | 0.4223 |
| 10:49 ET | 100 | 0.4223 |
| 10:56 ET | 201 | 0.4222 |
| 11:00 ET | 100 | 0.4223 |
| 11:02 ET | 300 | 0.4222 |
| 11:03 ET | 491 | 0.4222 |
| 11:05 ET | 1447 | 0.42 |
| 11:07 ET | 200 | 0.4101 |
| 11:14 ET | 6300 | 0.4166 |
| 11:18 ET | 500 | 0.41 |
| 11:20 ET | 200 | 0.423 |
| 11:25 ET | 4100 | 0.423 |
| 11:32 ET | 100 | 0.423 |
| 11:38 ET | 212 | 0.423 |
| 11:48 ET | 600 | 0.423 |
| 11:57 ET | 100 | 0.423 |
| 12:01 ET | 100 | 0.423 |
| 12:03 ET | 588 | 0.423 |
| 12:08 ET | 400 | 0.423 |
| 12:14 ET | 200 | 0.423 |
| 12:17 ET | 100 | 0.423 |
| 12:21 ET | 600 | 0.423 |
| 12:32 ET | 100 | 0.423 |
| 12:37 ET | 700 | 0.423 |
| 12:48 ET | 200 | 0.4165 |
| 12:55 ET | 600 | 0.423 |
| 01:02 ET | 100 | 0.4165 |
| 01:08 ET | 200 | 0.423 |
| 01:11 ET | 600 | 0.423 |
| 01:22 ET | 100 | 0.423 |
| 01:24 ET | 200 | 0.423 |
| 01:29 ET | 226 | 0.423 |
| 01:36 ET | 600 | 0.4233 |
| 01:38 ET | 100 | 0.4224 |
| 01:45 ET | 100 | 0.4224 |
| 01:51 ET | 700 | 0.4224 |
| 02:02 ET | 6856 | 0.4224 |
| 02:07 ET | 700 | 0.4237 |
| 02:09 ET | 100 | 0.425 |
| 02:16 ET | 100 | 0.42241 |
| 02:18 ET | 700 | 0.4224 |
| 02:23 ET | 600 | 0.43 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oncorus Inc | 11.0M | -0.1x | --- |
Weed Inc | 11.1M | -10.0x | --- |
Virax Biolabs Group Ltd | 11.2M | -6.1x | --- |
Kintara Therapeutics Inc | 10.8M | -0.3x | --- |
Kazia Therapeutics Ltd | 16.2M | -0.8x | --- |
BioRestorative Therapies Inc | 11.1M | -0.2x | --- |
Company Information
Oncorus, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing active viral immunotherapies to transform outcomes for cancer patients. Using its two platforms, the Company is developing a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and deliver transgenes to stimulate multiple arms of the immune system against tumors. Its lead product candidate, ONCR-177, is an intratumorally administered viral immunotherapy based on its oncolytic HSV-1 platform (oHSV Platform), which leverages the Herpes Simplex Virus type 1 (HSV-1). It is also developing a pipeline of product candidates based on its vRNA Immunotherapy Platform. This platform aims to enable repeat intravenous administration of viral immunotherapies in order to treat cancers that are less amenable to intratumoral injection due to safety and feasibility reasons, such as cancers of the lung.
Contact Information
- Headquarters
- 4 Corporate DriveANDOVER, MA, United States 01810
- Phone
- 857-320-6400
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Mitchell Finer
- President, Chief Executive Officer, Director
- Theodore Ashburn
- Chief Financial Officer
- Richard Wanstall
- Chief Operating Officer, Chief of Staff
- Stephen Harbin
- Senior Vice President - Research, Chief Scientific Officer
- Christophe Queva
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 26.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.95 |
Book Value | $5.03 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
